Neurofilament light protein in blood predicts regional atrophy in Huntington disease

Abstract

These findings highlight the value of NfL as a dynamic marker of brain atrophy and, more generally, provide further evidence of the strong association between plasma NfL level, a candidate blood biomarker, and pathologic neuronal change.